Read + Share
Amedeo Smart
Independent Medical Education
Orti G, Garcia-Gutierrez V, Bautista G, Ferrer-Marin F, et al. Tyrosine kinase inhibitor dose reduction during the management ofaccelerated phase chronic myeloid leukemia. Leuk Res 2022;121:106923.PMID: 35933910
Email
LinkedIn
Facebook
Twitter
Privacy Policy